Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ASH 2024 | The positive impact of a patient-co-created information resource for young people with MPNs

In this video, Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, comments on the importance of creating a bespoke information resource for young people with myeloproliferative neoplasms (MPNs), a condition often felt isolated by patients. Prof. Harrison highlights the success of a patient-co-created group, which has attracted over 300 members and aims to address specific needs, such as coping with the condition in personal and professional relationships, and provides a platform for young people to raise awareness and be heard. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript (AI generated)

One of the things we’ve become aware of in working with patients is that patients often feel that they don’t see another patient that looks like them. Many of our patients are on telephone follow-up and were during the pandemic, and those that come into the waiting room often don’t know the person in the waiting room’s got the same condition as them, for example. So we’ve recently set up a young person’s group for patients with MPN...

One of the things we’ve become aware of in working with patients is that patients often feel that they don’t see another patient that looks like them. Many of our patients are on telephone follow-up and were during the pandemic, and those that come into the waiting room often don’t know the person in the waiting room’s got the same condition as them, for example. So we’ve recently set up a young person’s group for patients with MPN. Young means under 40. Well, it still means, sadly, I don’t qualify, but it does mean that many of our patients will qualify. And there are specific things that are of need for that group. So really thinking about what do you tell an employer? How do you cope with a new relationship, for example, when you have this condition, making decisions about buying a house, fertility, pregnancy, et cetera. So first of all, there’s been wide enthusiasm for this group with over 300 members. It’s all run on Facebook. But what we did was, and this work was done by Alice Watson, who leads the patient group and is a patient herself. She’s very, very inspiring. And a colleague physician, Helen Oram, who works at King’s College London, but works with teenagers and young adults, mainly with sickle cell disease, but hopefully we can attract her to do some work in the MPN space too. And what they did was they showed some information that we have available already and then ran a survey past the young people and then did a kind of rapid change and then redress cycle. And so in the end, hopefully we have what will be a bit more bespoke for young people that flags what is needed for them and allows them also to raise awareness of this group and allows them to be a bit more cohesive and for us to hear their voice. What we’re doing next actually is we’re, as well as raising awareness of the young people’s group, colleagues who are listening have got young patients, please direct them to this group. There’s some paperwork available, but we’re also now going to try to write some specific guidelines for young patients with this condition, which hopefully will be helpful.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Disclosures

Sobi: Consultancy; Incyte: Consultancy, Honoraria, Other: Teaching and Speaking; Research: PI, Speakers Bureau; MPN voice: Other: Leadership role; Janssen: Consultancy; IMAGO: Consultancy, Honoraria, Speakers Bureau; BMS: Consultancy, Honoraria, Speakers Bureau; AOP: Consultancy, Honoraria, Speakers Bureau; CTI: Ended employment in the past 24 months; Keros: Consultancy, Honoraria, Speakers Bureau; Galecto: Consultancy; Geron: Consultancy; GSK: Consultancy, Honoraria, Other: Teaching and speaking; Research: PI, Research Funding, Speakers Bureau; MorphoSys/Constellation: Consultancy, Honoraria, Other: Research: PI, Research Funding, Speakers Bureau; AbbVie: Consultancy, Honoraria, Other: Teaching and speaking; Research: PI, Speakers Bureau; MSD: Consultancy, Honoraria, Speakers Bureau; Novartis: Consultancy, Honoraria, Other: Teaching and speaking; Research: PI, Research Funding, Speakers Bureau.